Inhibiting wear particles-induced osteolysis with naringin

International Orthopaedics

Volumn 37, Issue 1, 2013, Pages 137-143

  Yu, Xiaowei ^a   Zhao, Xingwei ^c   Wu, Tianyi ^b   Zhou, Zubin ^a   Gao, Youshui ^a   Wang, Xinfu ^a   Zhang, Chang Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AURANTIIN; COLONY STIMULATING FACTOR 1; N 1376; OSTEOCLAST DIFFERENTIATION FACTOR; POLY(METHYL METHACRYLATE); UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CALVARIA; CELL COUNT; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; METABOLIC INHIBITION; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCLASTOGENESIS INHIBITION; OSTEOLYSIS; OSTEOLYSIS INHIBITION; PARTICLE SIZE; PRIORITY JOURNAL; PROSTHESIS LOOSENING; QUANTITATIVE ANALYSIS; RABBIT; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; BONE RESORPTION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FLAVANONES; MICE; OSTEOCLASTS; OSTEOLYSIS; POLYMETHYL METHACRYLATE; RABBITS; SKULL; STAINING AND LABELING;

EID: 84871925965     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-012-1668-5     Document Type: Article

References (26)

1. Huo MH, Dumont GD, Knight JR, Mont MA (2011) What's new in total hip arthroplasty. J Bone Joint Surg Am 93:1944-1950
2. Billi F, Campbell P (2010) Nanotoxicology of metal wear particles in total joint arthroplasty: a review of current concepts. J Appl Biomater Biomech 8:1-6
3. Kaddick C, Catelas I, Pennekamp PH, Wimmer MA (2009) Implant wear and aseptic loosening. An overview. Orthopade 38:690-697
4. Zhang C, Tang T, Ren W, Zhang X, Dai K (2008) Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis. Inflamm Res 57:211-215
5. Baumann B, Rader CP, Seufert J, Noth U, Rolf O, Eulert J et al (2004) Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. Acta Orthop Scand 75:295-302
6. Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT (2006) The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum 54:3221-3232 (Pubitemid 44622093)
7. Wooley PH, Morren R, Andary J, Sud S, Yang SY, Mayton L et al (2002) Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23:517-526 (Pubitemid 33051040)
8. Epstein NJ, Warme BA, Spanogle J, Ma T, Bragg B, Smith RL et al (2005) Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 23:501-510 (Pubitemid 40631319)
9. Zhou X, Zhang C, Wang X, An B, Zhang P, Zhu Z (2012) Berberine inhibits lipopolysaccharide- and polyethylene particle-induced mouse calvarial osteolysis in vivo. J Surg Res 173:e47-e52
10. Zhang P, Qin L (2010) Potential use of erythromycin to prevent and treat prosthetic failure. J Clin Pharmacol 50:858-860
11. Catelas I, Jacobs JJ (2010) Biologic activity of wear particles. Instr Course Lect 59:3-16
12. Geng DC, Zhu XS, Mao HQ, Meng B, Chen L, Yang HL et al (2011) Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor. J Biomed Mater Res A 99:516-522
13. Markel DC, Zhang R, Shi T, Hawkins M, Ren W (2009) Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis. Inflamm Res 58:413-421
14. Wong RW, Rabie B, Bendeus M, Hagg U (2007) The effects of Rhizoma Curculiginis and Rhizoma Drynariae extracts on bones. Chin Med 2:13
15. Jeong JC, Lee JW, Yoon CH, Lee YC, Chung KH, Kim MG et al (2005) Stimulative effects of Drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells. J Ethnopharmacol 96:489-495 (Pubitemid 41556600)
16. Jeong JC, Kang SK, Youn CH, Jeong CW, Kim HM, Lee YC et al (2003) Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int Immunopharmacol 3:1685-1697 (Pubitemid 37211491)
17. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602 (Pubitemid 28173173)
18. Sobue T, Hakeda Y, Kobayashi Y, Hayakawa H, Yamashita K, Aoki T et al (2001) Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts. J Bone Miner Res 16:2205-2214 (Pubitemid 33104710)
19. Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN et al (2000) Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 18:849-855 (Pubitemid 32055754)
20. Goodman SB, Gomez Barrena E, Takagi M, Konttinen YT (2009) Biocompatibility of total joint replacements: a review. J Biomed Mater Res A 90:603-618
21. Ren W, Zhang R, Wu B, Wooley PH, Hawkins M, Markel DC (2011) Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model. J Inflamm Res 4:29-38
22. Zhang W, Zhao H, Peng X, Cheng T, Zhang X (2011) Low-dose captopril inhibits wear debris-induced inflammatory osteolysis. J Int Med Res 39:798-804
23. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM (2001) Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 16:338-347 (Pubitemid 32105415)
24. Schwarz EM, Looney RJ, O'Keefe RJ (2000) Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis. Arthritis Res 2:165-168 (Pubitemid 32223721)
25. Tsutsumi R, Hock C, Bechtold CD, Proulx ST, Bukata SV, Ito H et al (2008) Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT. J Orthop Res 26:1340-1346
26. Zhang P, Dai KR, Yan SG, Yan WQ, Zhang C, Chen DQ et al (2009) Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol 607:1-5